Jb Chemicals And Pharma
J.B. Chemicals and Pharmaceuticals Ltd., commonly referred to as J.B. Pharma, is a prominent player in the pharmaceutical industry, headquartered in Mumbai, India. Established in 1976, the company has made significant strides in the development and manufacturing of a diverse range of pharmaceutical products, including formulations and active pharmaceutical ingredients (APIs). With a strong presence in both domestic and international markets, J.B. Pharma focuses on therapeutic areas such as cardiology, gastroenterology, and anti-infectives. The company is renowned for its commitment to quality and innovation, which has positioned it as a trusted name in the industry. Notable achievements include a robust portfolio of over 100 products and a growing footprint in various global markets, underscoring its reputation as a reliable partner in healthcare solutions.
DitchCarbon Score
How does Jb Chemicals And Pharma's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Pharmaceutical Preparation Manufacturing industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Jb Chemicals And Pharma's score of 40 is higher than 64% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Jb Chemicals And Pharma's reported carbon emissions
In 2024, J.B. Chemicals and Pharmaceuticals reported total carbon emissions of approximately 206,000,000 kg CO2e. This includes Scope 1 emissions of about 8,691,000 kg CO2e, Scope 2 emissions of approximately 38,981,000 kg CO2e, and significant Scope 3 emissions totalling around 188,961,000 kg CO2e. The Scope 3 emissions breakdown reveals major contributions from purchased goods and services (about 106,010,000 kg CO2e) and downstream transportation and distribution (approximately 22,480,000 kg CO2e). Comparatively, in 2023, the company recorded total emissions of about 136,838,000 kg CO2e, with Scope 1 at approximately 10,097,000 kg CO2e and Scope 2 at around 45,282,000 kg CO2e. This indicates a notable increase in emissions in 2024, particularly in Scope 3 categories. J.B. Chemicals and Pharmaceuticals has set ambitious climate commitments, aiming to achieve carbon neutrality in its direct operations (Scope 1 and 2 emissions) by the fiscal year 2032-33. This long-term target reflects the company's commitment to reducing its carbon footprint and aligns with industry standards for sustainability. The emissions data is not cascaded from any parent organisation, indicating that J.B. Chemicals and Pharmaceuticals independently reports its emissions and climate initiatives. The company continues to focus on enhancing its sustainability practices while addressing its carbon emissions comprehensively.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2022 | 2023 | 2024 | |
|---|---|---|---|
| Scope 1 | 7,638,000 | 00,000,000 | 0,000,000 |
| Scope 2 | 45,030,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | 000,000,000 | 000,000,000 |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Jb Chemicals And Pharma is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
